Annals of Internal Medicine

Papers
(The H4-Index of Annals of Internal Medicine is 92. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application4308
Prevalence of Asymptomatic SARS-CoV-2 Infection1888
Autopsy Findings and Venous Thromboembolism in Patients With COVID-191637
Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure1081
Attitudes Toward a Potential SARS-CoV-2 Vaccine911
Psychological Impact of the COVID-19 Pandemic on Health Care Workers in Singapore796
Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths738
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome574
Worldwide Effect of COVID-19 on Physical Activity: A Descriptive Study566
Collision of the COVID-19 and Addiction Epidemics525
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors511
Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2456
Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers437
Sixty-Day Outcomes Among Patients Hospitalized With COVID-19434
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization412
COVID-19 and the Risk to Health Care Workers: A Case Report400
Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak400
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19395
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic395
Systemic Lupus Erythematosus340
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19337
The Unrecognized Prevalence of Primary Aldosteronism313
A War on Two Fronts: Cancer Care in the Time of COVID-19291
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series277
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers257
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19250
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy249
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2247
Knowledge and Perceptions of COVID-19 Among the General Public in the United States and the United Kingdom: A Cross-sectional Online Survey243
SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection236
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia233
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19221
Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building186
Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic183
Depression183
Supporting Clinicians During the COVID-19 Pandemic180
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes178
This Time Must Be Different: Disparities During the COVID-19 Pandemic170
Reduced In-Person and Increased Telehealth Outpatient Visits During the COVID-19 Pandemic170
SARS-CoV-2–Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19169
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis168
Chronic Obstructive Pulmonary Disease166
Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China165
Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection164
The Role of Medical Students During the COVID-19 Pandemic160
COVID-19: Peer Support and Crisis Communication Strategies to Promote Institutional Resilience160
COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings158
Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate157
The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs151
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know150
Patient Trajectories Among Persons Hospitalized for COVID-19147
Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19146
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19146
Conversion of Urine Protein–Creatinine Ratio or Urine Dipstick Protein to Urine Albumin–Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis144
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19141
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020133
Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness132
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults130
Ventilator Triage Policies During the COVID-19 Pandemic at U.S. Hospitals Associated With Members of the Association of Bioethics Program Directors128
How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)?126
Racial Disparities in COVID-19 Testing and Outcomes123
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?121
Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles119
Isradipine Versus Placebo in Early Parkinson Disease117
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis116
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments115
Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants114
Myasthenia Gravis Associated With SARS-CoV-2 Infection114
Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France112
Caution Warranted: Using the Institute for Health Metrics and Evaluation Model for Predicting the Course of the COVID-19 Pandemic109
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline108
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2105
Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings105
Sex and Gender Differences in Health: What the COVID-19 Pandemic Can Teach Us105
Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting104
Communication Skills in the Age of COVID-19104
Delirium103
A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States103
Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 U.S. Cities103
Firearm Purchasing During the COVID-19 Pandemic: Results From the 2021 National Firearms Survey101
Intersecting U.S. Epidemics: COVID-19 and Lack of Health Insurance101
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings100
A SARS-CoV-2 Cluster in an Acute Care Hospital100
Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled Comparison in 4 Patients99
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis98
A Novel International Monkeypox Outbreak98
Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults98
Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine97
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting96
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis96
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-1994
Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 202093
Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible92
Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series92
0.083237171173096